Suchergebnisse - "Kobayashi, Mariko"

PubPharm (28)

1

Complex Association of Virus- and Host-Related Factors with Hepatocellular Carcinoma Rate following Hepatitis C Virus Clearance

enthalten in: Journal of clinical microbiology | 2019

von Akuta, N. | Suzuki, F. | Sezaki, H. | +10

2

Amino acid substitutions in the hepatitis C virus core region predict hepatocarcinogenesis following eradication of HCV RNA by all-oral direct-acting antiviral regimens

enthalten in: Journal of medical virology | 2018

von Ogata, F. | Akuta, N. | Kobayashi, M. | +11

3

Impact of Mutations at Amino Acid 70 in Hepatitis C Virus (HCV) Genotype 1b Core Region on Hepatocarcinogenesis following Eradication of HCV RNA

enthalten in: Journal of clinical microbiology | 2015

von Akuta, N. | Suzuki, F. | Kobayashi, M. | +9

4

Comparative quantitative analysis of hepatitis C mutations at amino acids 70 and 91 in the core region by the Q-Invader assay

enthalten in: Journal of virological methods | 2013

von Tadokoro, K. | Kobayashi, M. | Suzuki, F. | +5

5

Amino acid substitutions in the hepatitis C Virus core region and lipid metabolism are associated with hepatocarcinogenesis in nonresponders to interferon plus ribavirin combination therapy

enthalten in: Intervirology | 2013

von Seko, Y. | Akuta, N. | Suzuki, F. | +10

6

Complicated relationships of amino acid substitution in hepatitis C virus core region and IL28B genotype influencing hepatocarcinogenesis

enthalten in: Hepatology (Baltimore, Md.) | 2012

von Akuta, N. | Suzuki, F. | Seko, Y. | +11

7

Long-term interferon monotherapy reduces the risk of HCV-associated hepatocellular carcinoma

enthalten in: Journal of medical virology | 2012

von Takeyasu, M. | Akuta, N. | Suzuki, F. | +10

8

Amino acid substitution in HCV core region and genetic variation near the IL28B gene affect viral dynamics during telaprevir, peginterferon and ribavirin treatment

enthalten in: Intervirology | 2012

von Akuta, N. | Suzuki, F. | Hirakawa, M. | +13

9

Amino acid substitution in HCV core/NS5A region and genetic variation near IL28B gene affect treatment efficacy to interferon plus ribavirin combination therapy

enthalten in: Intervirology | 2012

von Akuta, N. | Suzuki, F. | Hirakawa, M. | +12

10

IL28B but not ITPA polymorphism is predictive of response to pegylated interferon, ribavirin, and telaprevir triple therapy in patients with genotype 1 hepatitis C

enthalten in: The Journal of infectious diseases | 2011

von Chayama, K. | Hayes, C. | Abe, H. | +11